Overlooked Issues on Pharmacokinetics Data Interpretation of Protein Drugs – A Case Example of Erythropoietin

類似資料

• Differential pharmacokinetic analysis of in vivo erythropoietin receptor interaction with erythropoietin and continuous erythropoietin receptor activator in sheep
  著者:: El-Komy, Mohammed H., 等
  出版事項: (2011)
• Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin
  著者:: Veng-Pedersen, Peter, 等
  出版事項: (2008)
• Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia
  著者:: Neelakantan, Srividya, 等
  出版事項: (2009)
• Target-Mediated Disposition Population Pharmacokinetics Model of Erythropoietin in Premature Neonates Following Multiple Intravenous and Subcutaneous Dosing Regimens
  著者:: D’Cunha, Ronilda, 等
  出版事項: (2019)
• A Mechanism-Based Population Pharmacokinetics Model of Erythropoietin in Premature Infants and Healthy Adults Following Multiple Intravenous Doses
  著者:: D’Cunha, Ronilda, 等
  出版事項: (2019)